APAC Cancer Diagnostics Market is Expected to Grow at a CAGR of 12.7% by value during 2017-2024
ReportsWeb.com published “Cancer Diagnostics Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, December 13, 2017 ) APAC cancer diagnostics is expected to reach USD 7.10 billion by 2024 from USD 2.70 billion in 2016, at a CAGR of 12.7% in the forecast period 2017 to 2024.
The major factors driving the growth of market are the technological development, increasing medical tourism in Asia Pacific regions and increasing market reach by Asian countries.
Based on geography, the APAC cancer diagnostics market is segmented into 11 geographical regions, such as,
Japan,
China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest of APAC.
Request a sample copy at http://www.reportsweb.com/inquiry&RW00011194764/sample
APAC cancer diagnostics market competition by top players including:-
F. Hoffman-La Roche Ltd is going to dominate the cancer diagnostics market, by platform based following with Abbott Laboratories Inc., along with QIAGEN.
The APAC cancer diagnostics market is segmented on the basis of technology, application and geography.
on the basis technology, APAC cancer diagnostics market is segmented into 2 types-platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2%.
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others.
Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), mammography and ultrasound.
On the basis of application, the APAC cancer diagnostics market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Table of Content:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Apac Cancer Diagnostics Market, By Technology
7. Apac Cancer Diagnostics Market, By Application
8. Apac Cancer Diagnostics Market, By Geography
9. Apac Cancer Diagnostics Market, Company Landscape
10. Company Profiles
For more information about this report at http://www.reportsweb.com/apac-cancer-diagnostics-market-analysis-and-forecast-to-2024
The major factors driving the growth of market are the technological development, increasing medical tourism in Asia Pacific regions and increasing market reach by Asian countries.
Based on geography, the APAC cancer diagnostics market is segmented into 11 geographical regions, such as,
Japan,
China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest of APAC.
Request a sample copy at http://www.reportsweb.com/inquiry&RW00011194764/sample
APAC cancer diagnostics market competition by top players including:-
F. Hoffman-La Roche Ltd is going to dominate the cancer diagnostics market, by platform based following with Abbott Laboratories Inc., along with QIAGEN.
The APAC cancer diagnostics market is segmented on the basis of technology, application and geography.
on the basis technology, APAC cancer diagnostics market is segmented into 2 types-platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2%.
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others.
Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), mammography and ultrasound.
On the basis of application, the APAC cancer diagnostics market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Table of Content:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Apac Cancer Diagnostics Market, By Technology
7. Apac Cancer Diagnostics Market, By Application
8. Apac Cancer Diagnostics Market, By Geography
9. Apac Cancer Diagnostics Market, Company Landscape
10. Company Profiles
For more information about this report at http://www.reportsweb.com/apac-cancer-diagnostics-market-analysis-and-forecast-to-2024
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results